{"transactions":[{"id":677463,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":20372,"kind":"person","name":"Hively Brad","position":1,"cik":"0001891124","reported_name":"Hively Brad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-24T21:11:12.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":298853,"price":6.5126,"value":1946310.0478,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.37 to $6.75 per share. Upon request by the SEC, the Issuer or a stockholder of the Issuer, complete information regarding the number of shares sold at each price within the range will be provided."}],"balance_after":411976,"source":{"system":"sec-edgar","filing":"0001079973-26-001175","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326001175/ownership.xml","form_type":"4"}},{"id":685815,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":22971,"kind":"person","name":"Chernett Jorey","position":1,"cik":"0002042077","reported_name":"Chernett Jorey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Call Option (STLN 19FEB27 $9C)","published_at":"2026-08-17T14:13:13.000Z","date":"2026-08-13","kind":"sale","planned":false,"acquired":false,"shares":100,"price":6.24,"value":624.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The sale of these call options is a matchable transaction subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer."}],"balance_after":0,"derivative":{"exercise_price":9,"exercise_date":"2026-08-13","expiration_date":"2027-02-19","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000921895-26-002203","document":"form414528003stln_08172026.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2042077/000092189526002203/form414528003stln_08172026.xml","form_type":"4"}},{"id":685814,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":22971,"kind":"person","name":"Chernett Jorey","position":1,"cik":"0002042077","reported_name":"Chernett Jorey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-17T14:13:13.000Z","date":"2026-08-14","kind":"purchase","planned":false,"acquired":true,"shares":12000,"price":6.54,"value":78480.0,"ownership":{"direct":true},"balance_after":10660858,"source":{"system":"sec-edgar","filing":"0000921895-26-002203","document":"form414528003stln_08172026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042077/000092189526002203/form414528003stln_08172026.xml","form_type":"4"}},{"id":701484,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28032,"kind":"person","name":"Kaushal Mohit","position":1,"cik":"0001683021","reported_name":"Kaushal Mohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-29T22:56:37.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":33133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date."}],"balance_after":205716,"source":{"system":"sec-edgar","filing":"0001079973-26-000993","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000993/ownership.xml","form_type":"4"}},{"id":701482,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-29T22:54:49.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":41165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date."}],"balance_after":332535,"source":{"system":"sec-edgar","filing":"0001079973-26-000991","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000991/ownership.xml","form_type":"4"}},{"id":701483,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28031,"kind":"person","name":"Pacala Mark L","position":1,"cik":"0001321250","reported_name":"Pacala Mark L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-29T22:53:11.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":30120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date."}],"balance_after":286881,"source":{"system":"sec-edgar","filing":"0001079973-26-000989","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000989/ownership.xml","form_type":"4"}},{"id":701481,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28030,"kind":"person","name":"STOLPER MARK","position":1,"cik":"0001281961","reported_name":"STOLPER MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-29T22:52:10.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":31124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date."}],"balance_after":56957,"source":{"system":"sec-edgar","filing":"0001079973-26-000987","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000987/ownership.xml","form_type":"4"}},{"id":701479,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28029,"kind":"person","name":"TZOUMAKAS KIMBERLY JO","position":1,"cik":"0001766666","reported_name":"TZOUMAKAS KIMBERLY JO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-29T22:50:40.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":29116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date."}],"balance_after":46301,"source":{"system":"sec-edgar","filing":"0001079973-26-000985","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000985/ownership.xml","form_type":"4"}},{"id":701480,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":20372,"kind":"person","name":"Hively Brad","position":1,"cik":"0001891124","reported_name":"Hively Brad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-29T22:49:15.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":27108,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date."}],"balance_after":710829,"source":{"system":"sec-edgar","filing":"0001079973-26-000983","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000983/ownership.xml","form_type":"4"}},{"id":701478,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28028,"kind":"person","name":"Johnson Karen Marie","position":1,"cik":"0001892819","reported_name":"Johnson Karen Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-29T22:46:17.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":31124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date."}],"balance_after":319410,"source":{"system":"sec-edgar","filing":"0001079973-26-000981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000981/ownership.xml","form_type":"4"}},{"id":704841,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":22971,"kind":"person","name":"Chernett Jorey","position":1,"cik":"0002042077","reported_name":"Chernett Jorey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-07-22T13:55:25.000Z","date":"2026-07-21","kind":"purchase","planned":false,"acquired":true,"shares":18000,"price":5.27,"value":94860.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $5.27 to $5.28, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased."}],"balance_after":10648858,"source":{"system":"sec-edgar","filing":"0000921895-26-001852","document":"form414528003_07222026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042077/000092189526001852/form414528003_07222026.xml","form_type":"4"}},{"id":708097,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":30089,"kind":"person","name":"Podnos Yale","position":1,"cik":"0001891104","reported_name":"Podnos Yale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T00:05:50.000Z","date":"2026-07-14","kind":"exercise","planned":true,"acquired":true,"shares":5478,"price":2,"value":10956.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options described above were originally granted on 11/17/2022 and 05/21/2024, respectively, and vested in accordance with their respective terms."}],"balance_after":0,"derivative":{"exercise_price":2,"expiration_date":"2034-05-21","underlying":"Common Stock","underlying_shares":5478},"source":{"system":"sec-edgar","filing":"0001553350-26-000111","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335026000111/ownership.xml","form_type":"4"}},{"id":708096,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":30089,"kind":"person","name":"Podnos Yale","position":1,"cik":"0001891104","reported_name":"Podnos Yale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T00:05:50.000Z","date":"2026-07-14","kind":"exercise","planned":true,"acquired":true,"shares":17974,"price":1.87,"value":33611.38,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options described above were originally granted on 11/17/2022 and 05/21/2024, respectively, and vested in accordance with their respective terms."}],"balance_after":0,"derivative":{"exercise_price":1.87,"expiration_date":"2032-11-17","underlying":"Common Stock","underlying_shares":17974},"source":{"system":"sec-edgar","filing":"0001553350-26-000111","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335026000111/ownership.xml","form_type":"4"}},{"id":708095,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":30089,"kind":"person","name":"Podnos Yale","position":1,"cik":"0001891104","reported_name":"Podnos Yale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-17T00:05:50.000Z","date":"2026-07-14","kind":"sale","planned":true,"acquired":false,"shares":5478,"price":6.35,"value":34785.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale transactions were effected pursuant to a Rule 10(b) 5-1 trading plan adopted by the Reporting Person on 08/26/2025."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in Table I reflect shares acquired upon exercise of the options identified in Table II, sold on the same day pursuant to the 10(b) 5-1 plan referenced in Footnote 1."}],"balance_after":259527,"source":{"system":"sec-edgar","filing":"0001553350-26-000111","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335026000111/ownership.xml","form_type":"4"}},{"id":708094,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":30089,"kind":"person","name":"Podnos Yale","position":1,"cik":"0001891104","reported_name":"Podnos Yale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-17T00:05:50.000Z","date":"2026-07-14","kind":"exercise","planned":true,"acquired":true,"shares":5478,"price":2,"value":10956.0,"ownership":{"direct":true},"balance_after":265005,"source":{"system":"sec-edgar","filing":"0001553350-26-000111","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335026000111/ownership.xml","form_type":"4"}},{"id":708093,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":30089,"kind":"person","name":"Podnos Yale","position":1,"cik":"0001891104","reported_name":"Podnos Yale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-17T00:05:50.000Z","date":"2026-07-14","kind":"sale","planned":true,"acquired":false,"shares":17974,"price":6.429,"value":115554.846,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale transactions were effected pursuant to a Rule 10(b) 5-1 trading plan adopted by the Reporting Person on 08/26/2025."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in Table I reflect shares acquired upon exercise of the options identified in Table II, sold on the same day pursuant to the 10(b) 5-1 plan referenced in Footnote 1."}],"balance_after":259527,"source":{"system":"sec-edgar","filing":"0001553350-26-000111","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335026000111/ownership.xml","form_type":"4"}},{"id":708092,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":30089,"kind":"person","name":"Podnos Yale","position":1,"cik":"0001891104","reported_name":"Podnos Yale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-17T00:05:50.000Z","date":"2026-07-14","kind":"exercise","planned":true,"acquired":true,"shares":17974,"price":1.87,"value":33611.38,"ownership":{"direct":true},"balance_after":277501,"source":{"system":"sec-edgar","filing":"0001553350-26-000111","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335026000111/ownership.xml","form_type":"4"}},{"id":710741,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":22971,"kind":"person","name":"Chernett Jorey","position":1,"cik":"0002042077","reported_name":"Chernett Jorey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-07-13T15:34:14.000Z","date":"2026-07-10","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":5.85,"value":87750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $5.82 to $5.90, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased."}],"balance_after":10630858,"source":{"system":"sec-edgar","filing":"0000921895-26-001798","document":"form414528001_07132026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042077/000092189526001798/form414528001_07132026.xml","form_type":"4"}},{"id":711855,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28029,"kind":"person","name":"TZOUMAKAS KIMBERLY JO","position":1,"cik":"0001766666","reported_name":"TZOUMAKAS KIMBERLY JO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-09T20:30:02.000Z","date":"2026-07-07","kind":"grant","planned":false,"acquired":true,"shares":17185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents RSU award that was fully vested upon grant"}],"balance_after":17185,"source":{"system":"sec-edgar","filing":"0001079973-26-000940","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000940/ownership.xml","form_type":"4"}},{"id":711844,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28030,"kind":"person","name":"STOLPER MARK","position":1,"cik":"0001281961","reported_name":"STOLPER MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-09T20:30:01.000Z","date":"2026-07-07","kind":"grant","planned":false,"acquired":true,"shares":25833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents RSU award that was fully vested upon grant."}],"balance_after":25833,"source":{"system":"sec-edgar","filing":"0001079973-26-000939","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000939/ownership.xml","form_type":"4"}},{"id":727930,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":22971,"kind":"person","name":"Chernett Jorey","position":1,"cik":"0002042077","reported_name":"Chernett Jorey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T13:31:24.000Z","date":"2026-06-23","kind":"purchase","planned":false,"acquired":true,"shares":18000,"price":5.02,"value":90360.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $5.02 to $5.04, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased."}],"balance_after":10615858,"source":{"system":"sec-edgar","filing":"0000921895-26-001657","document":"form414528003_06242026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042077/000092189526001657/form414528003_06242026.xml","form_type":"4"}},{"id":744724,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":30089,"kind":"person","name":"Podnos Yale","position":1,"cik":"0001891104","reported_name":"Podnos Yale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-09T23:06:28.000Z","date":"2026-06-08","kind":"sale","planned":true,"acquired":false,"shares":23451,"price":5.3769,"value":126093.6819,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Price is the volume weighted average selling price of all sales on behalf of the Reporting Person on June 8, 2028 within a one-dollar range. Actual prices ranged from $5.35 to $5.42. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Sales were made on behalf of the Reporting Person pursuant to the Rule 10b5-1(c) plan that was adopted on 08/26/2025."}],"balance_after":259527,"source":{"system":"sec-edgar","filing":"0001079973-26-000801","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000801/ownership.xml","form_type":"4"}},{"id":748361,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":22971,"kind":"person","name":"Chernett Jorey","position":1,"cik":"0002042077","reported_name":"Chernett Jorey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T13:38:06.000Z","date":"2026-06-04","kind":"purchase","planned":false,"acquired":true,"shares":12000,"price":4.75,"value":57000.0,"ownership":{"direct":true},"balance_after":10579858,"source":{"system":"sec-edgar","filing":"0000921895-26-001564","document":"form414528003_06052026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042077/000092189526001564/form414528003_06052026.xml","form_type":"4"}},{"id":766064,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":30089,"kind":"person","name":"Podnos Yale","position":1,"cik":"0001891104","reported_name":"Podnos Yale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-22T21:39:44.000Z","date":"2026-05-21","kind":"other","planned":false,"acquired":false,"shares":1805,"price":4.47,"value":8068.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award made on May 21, 2024."}],"balance_after":282978,"source":{"system":"sec-edgar","filing":"0001079973-26-000727","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000727/ownership.xml","form_type":"4"}},{"id":766063,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44753,"kind":"person","name":"Virnich Daniel","position":1,"cik":"0001891107","reported_name":"Virnich Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-22T21:37:58.000Z","date":"2026-05-21","kind":"other","planned":false,"acquired":false,"shares":23058,"price":4.47,"value":103069.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award made on May 21, 2024."}],"balance_after":2337166,"source":{"system":"sec-edgar","filing":"0001079973-26-000725","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000725/ownership.xml","form_type":"4"}},{"id":766380,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44812,"kind":"person","name":"Carter Robert Ross","position":1,"cik":"0002039341","reported_name":"Carter Robert Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-22T21:32:19.000Z","date":"2026-05-21","kind":"other","planned":false,"acquired":false,"shares":1604,"price":4.47,"value":7169.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award made on May 21, 2024."}],"balance_after":414801,"source":{"system":"sec-edgar","filing":"0001079973-26-000723","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039341/000107997326000723/ownership.xml","form_type":"4"}},{"id":768311,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":22971,"kind":"person","name":"Chernett Jorey","position":1,"cik":"0002042077","reported_name":"Chernett Jorey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T13:35:48.000Z","date":"2026-05-20","kind":"purchase","planned":false,"acquired":true,"shares":33500,"price":4.07,"value":136345.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $4.05 to $4.10, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased."}],"balance_after":10567858,"source":{"system":"sec-edgar","filing":"0000921895-26-001466","document":"form414528003_05212026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2042077/000092189526001466/form414528003_05212026.xml","form_type":"4"}},{"id":768310,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":22971,"kind":"person","name":"Chernett Jorey","position":1,"cik":"0002042077","reported_name":"Chernett Jorey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T13:35:48.000Z","date":"2026-05-19","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.05,"value":20250.0,"ownership":{"direct":true},"balance_after":10534358,"source":{"system":"sec-edgar","filing":"0000921895-26-001466","document":"form414528003_05212026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042077/000092189526001466/form414528003_05212026.xml","form_type":"4"}},{"id":770290,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":22971,"kind":"person","name":"Chernett Jorey","position":1,"cik":"0002042077","reported_name":"Chernett Jorey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T16:25:29.000Z","date":"2026-05-19","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":4.09,"value":122700.0,"ownership":{"direct":true},"balance_after":10529358,"source":{"system":"sec-edgar","filing":"0000921895-26-001444","document":"form414528003toi_05202026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042077/000092189526001444/form414528003toi_05202026.xml","form_type":"4"}},{"id":807135,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28032,"kind":"person","name":"Kaushal Mohit","position":1,"cik":"0001683021","reported_name":"Kaushal Mohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-16T23:27:23.000Z","date":"2026-04-16","kind":"sale","planned":true,"acquired":false,"shares":38433,"price":3.5005,"value":134534.7165,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Price of $3.5005 was the volume weighted average selling price of all sales by the reporting person on April 16, 2026 within a one-dollar range. Actual prices ranged from $3.5000 to $3.5050. The reporting person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price."}],"balance_after":172583,"source":{"system":"sec-edgar","filing":"0001079973-26-000499","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000499/ownership.xml","form_type":"4"}},{"id":807134,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28032,"kind":"person","name":"Kaushal Mohit","position":1,"cik":"0001683021","reported_name":"Kaushal Mohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-16T23:27:23.000Z","date":"2026-04-14","kind":"sale","planned":true,"acquired":false,"shares":57286,"price":3.5017,"value":200598.3862,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 16, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price of $3.5017 was the volume weighted average selling price of all sales by the reporting person on April 14, 2026 within a one-dollar range. Actual prices ranged from $3.5000 to $3.5300. The reporting person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price."}],"balance_after":211016,"source":{"system":"sec-edgar","filing":"0001079973-26-000499","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000499/ownership.xml","form_type":"4"}},{"id":809794,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":22971,"kind":"person","name":"Chernett Jorey","position":1,"cik":"0002042077","reported_name":"Chernett Jorey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-13T13:03:52.000Z","date":"2026-04-09","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":3.1,"value":62000.0,"ownership":{"direct":true},"balance_after":10499358,"source":{"system":"sec-edgar","filing":"0000921895-26-000958","document":"form414528003_04132026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042077/000092189526000958/form414528003_04132026.xml","form_type":"4"}},{"id":823221,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":51504,"kind":"person","name":"Langsam Jeffrey","position":1,"cik":"0002069752","reported_name":"Langsam Jeffrey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Officer"}}],"security":"Common Stock","published_at":"2026-04-02T01:00:00.000Z","date":"2026-03-27","kind":"grant","planned":false,"acquired":true,"shares":70270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates."}],"balance_after":127650,"source":{"system":"sec-edgar","filing":"0001079973-26-000449","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2069752/000107997326000449/ownership.xml","form_type":"4"}},{"id":822938,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":51489,"kind":"person","name":"England Kristin","position":1,"cik":"0002078090","reported_name":"England Kristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Common Stock","published_at":"2026-04-02T00:57:33.000Z","date":"2026-03-27","kind":"grant","planned":false,"acquired":true,"shares":55743,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates"}],"balance_after":153780,"source":{"system":"sec-edgar","filing":"0001079973-26-000447","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000447/ownership.xml","form_type":"4"}},{"id":822940,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":30089,"kind":"person","name":"Podnos Yale","position":1,"cik":"0001891104","reported_name":"Podnos Yale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-02T00:51:29.000Z","date":"2026-03-27","kind":"other","planned":false,"acquired":false,"shares":16173,"price":3.07,"value":49651.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on March 31, 2026."}],"balance_after":284783,"source":{"system":"sec-edgar","filing":"0001079973-26-000443","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000443/ownership.xml","form_type":"4"}},{"id":822939,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":30089,"kind":"person","name":"Podnos Yale","position":1,"cik":"0001891104","reported_name":"Podnos Yale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-02T00:51:29.000Z","date":"2026-03-27","kind":"grant","planned":false,"acquired":true,"shares":66446,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates."}],"balance_after":300956,"source":{"system":"sec-edgar","filing":"0001079973-26-000443","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000443/ownership.xml","form_type":"4"}},{"id":823177,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44812,"kind":"person","name":"Carter Robert Ross","position":1,"cik":"0002039341","reported_name":"Carter Robert Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-02T00:47:21.000Z","date":"2026-03-27","kind":"other","planned":false,"acquired":false,"shares":20320,"price":3.07,"value":62382.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on March 31, 2026"}],"balance_after":416405,"source":{"system":"sec-edgar","filing":"0001079973-26-000440","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2039341/000107997326000440/ownership.xml","form_type":"4"}},{"id":823176,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44812,"kind":"person","name":"Carter Robert Ross","position":1,"cik":"0002039341","reported_name":"Carter Robert Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-02T00:47:21.000Z","date":"2026-03-27","kind":"grant","planned":false,"acquired":false,"shares":202914,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates."}],"balance_after":436725,"source":{"system":"sec-edgar","filing":"0001079973-26-000440","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039341/000107997326000440/ownership.xml","form_type":"4"}},{"id":822937,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44753,"kind":"person","name":"Virnich Daniel","position":1,"cik":"0001891107","reported_name":"Virnich Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-02T00:46:38.000Z","date":"2026-03-27","kind":"other","planned":false,"acquired":false,"shares":98534,"price":3.07,"value":302499.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on March 31, 2026."}],"balance_after":2360224,"source":{"system":"sec-edgar","filing":"0001079973-26-000439","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000439/ownership.xml","form_type":"4"}},{"id":822936,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44753,"kind":"person","name":"Virnich Daniel","position":1,"cik":"0001891107","reported_name":"Virnich Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-02T00:46:38.000Z","date":"2026-03-27","kind":"grant","planned":false,"acquired":false,"shares":670608,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates."}],"balance_after":2458758,"source":{"system":"sec-edgar","filing":"0001079973-26-000439","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000439/ownership.xml","form_type":"4"}},{"id":825433,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":22971,"kind":"person","name":"Chernett Jorey","position":1,"cik":"0002042077","reported_name":"Chernett Jorey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-30T13:38:04.000Z","date":"2026-03-27","kind":"purchase","planned":false,"acquired":true,"shares":27429,"price":2.96,"value":81189.84,"ownership":{"direct":true},"balance_after":10479358,"source":{"system":"sec-edgar","filing":"0000921895-26-000823","document":"form414528003toi_03302026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042077/000092189526000823/form414528003toi_03302026.xml","form_type":"4"}},{"id":826629,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":22971,"kind":"person","name":"Chernett Jorey","position":1,"cik":"0002042077","reported_name":"Chernett Jorey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-27T13:34:25.000Z","date":"2026-03-26","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":3.15,"value":157500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $3.11 to $3.19, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased."}],"balance_after":10451929,"source":{"system":"sec-edgar","filing":"0000921895-26-000814","document":"form414528003toi_03272026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042077/000092189526000814/form414528003toi_03272026.xml","form_type":"4"}},{"id":828354,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":22971,"kind":"person","name":"Chernett Jorey","position":1,"cik":"0002042077","reported_name":"Chernett Jorey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-25T13:33:09.000Z","date":"2026-03-24","kind":"purchase","planned":false,"acquired":true,"shares":125000,"price":3.11,"value":388750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $3.04 to $3.15, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased."}],"balance_after":10401929,"source":{"system":"sec-edgar","filing":"0000921895-26-000796","document":"form414528003_03252026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042077/000092189526000796/form414528003_03252026.xml","form_type":"4"}},{"id":831040,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":22971,"kind":"person","name":"Chernett Jorey","position":1,"cik":"0002042077","reported_name":"Chernett Jorey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-23T13:33:11.000Z","date":"2026-03-20","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":3.35,"value":83750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $3.33 to $3.35, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased."}],"balance_after":10276929,"source":{"system":"sec-edgar","filing":"0001193805-26-000306","document":"e665269_4-toi.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042077/000119380526000306/e665269_4-toi.xml","form_type":"4"}},{"id":835082,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44753,"kind":"person","name":"Virnich Daniel","position":1,"cik":"0001891107","reported_name":"Virnich Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-18T21:21:35.000Z","date":"2026-03-17","kind":"other","planned":false,"acquired":false,"shares":11834,"price":3.59,"value":42484.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on March 17, 2026."}],"balance_after":1788150,"source":{"system":"sec-edgar","filing":"0001079973-26-000332","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000332/ownership.xml","form_type":"4"}},{"id":835404,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44812,"kind":"person","name":"Carter Robert Ross","position":1,"cik":"0002039341","reported_name":"Carter Robert Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-18T21:20:19.000Z","date":"2026-03-17","kind":"other","planned":false,"acquired":false,"shares":1314,"price":3.59,"value":4717.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on March 17, 2026."}],"balance_after":233811,"source":{"system":"sec-edgar","filing":"0001079973-26-000330","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039341/000107997326000330/ownership.xml","form_type":"4"}},{"id":835081,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":30089,"kind":"person","name":"Podnos Yale","position":1,"cik":"0001891104","reported_name":"Podnos Yale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-18T21:19:09.000Z","date":"2026-03-17","kind":"other","planned":false,"acquired":false,"shares":3420,"price":3.59,"value":12277.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on March 17, 2026."}],"balance_after":234510,"source":{"system":"sec-edgar","filing":"0001079973-26-000328","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000328/ownership.xml","form_type":"4"}},{"id":838675,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":22971,"kind":"person","name":"Chernett Jorey","position":1,"cik":"0002042077","reported_name":"Chernett Jorey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-17T23:40:00.000Z","date":"2026-03-17","kind":"purchase","planned":false,"acquired":true,"shares":75000,"price":3.42,"value":256500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $3.39 to $3.49, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased."}],"balance_after":10251929,"source":{"system":"sec-edgar","filing":"0000921895-26-000712","document":"form414528003_03172026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2042077/000092189526000712/form414528003_03172026.xml","form_type":"4"}},{"id":838674,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":22971,"kind":"person","name":"Chernett Jorey","position":1,"cik":"0002042077","reported_name":"Chernett Jorey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-17T23:40:00.000Z","date":"2026-03-16","kind":"purchase","planned":false,"acquired":true,"shares":60985,"price":3.29,"value":200640.65,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $3.25 to $3.43, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased."}],"balance_after":10176929,"source":{"system":"sec-edgar","filing":"0000921895-26-000712","document":"form414528003_03172026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2042077/000092189526000712/form414528003_03172026.xml","form_type":"4"}},{"id":838673,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":22971,"kind":"person","name":"Chernett Jorey","position":1,"cik":"0002042077","reported_name":"Chernett Jorey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-17T23:40:00.000Z","date":"2026-03-13","kind":"purchase","planned":false,"acquired":true,"shares":263000,"price":2.92,"value":767960.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $2.77 to $3.34, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased."}],"balance_after":10115944,"source":{"system":"sec-edgar","filing":"0000921895-26-000712","document":"form414528003_03172026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042077/000092189526000712/form414528003_03172026.xml","form_type":"4"}},{"id":947342,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44812,"kind":"person","name":"Carter Robert Ross","position":1,"cik":"0002039341","reported_name":"Carter Robert Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-06T21:30:02.000Z","date":"2026-01-02","kind":"other","planned":false,"acquired":false,"shares":244,"price":3.67,"value":895.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on January 1, 2026."}],"balance_after":235125,"source":{"system":"sec-edgar","filing":"0001079973-26-000039","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039341/000107997326000039/ownership.xml","form_type":"4/A","original_submission_date":"2026-01-05"}},{"id":952312,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44812,"kind":"person","name":"Carter Robert Ross","position":1,"cik":"0002039341","reported_name":"Carter Robert Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-05T22:04:59.000Z","date":"2026-01-02","kind":"sale","planned":false,"acquired":false,"shares":247,"price":3.56,"value":879.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person used the proceeds of this sale to cover tax liabilities arising from the vesting of an RSU award on January 1, 2026."}],"balance_after":235122,"source":{"system":"sec-edgar","filing":"0001079973-26-000008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039341/000107997326000008/ownership.xml","form_type":"4"}},{"id":967646,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":20372,"kind":"person","name":"Hively Brad","position":1,"cik":"0001891124","reported_name":"Hively Brad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-16T21:30:05.000Z","date":"2025-12-15","kind":"sale","planned":false,"acquired":false,"shares":13333,"price":3.7719,"value":50290.7427,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person used the proceeds of this sale to cover tax liabilities arising from the vesting of an RSU award on November 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price of $3.771921 was the volume weighted average selling price of all sales by the reporting person on December 15, 2025 within a one-dollar range. Actual prices ranged from $3.770 to $3.785. The reporting person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price."}],"balance_after":683721,"source":{"system":"sec-edgar","filing":"0001079973-25-001861","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997325001861/ownership.xml","form_type":"4"}},{"id":990204,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-24T22:26:26.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":40123,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":". Represents restricted stock units that were fully vested upon grant."}],"balance_after":291370,"source":{"system":"sec-edgar","filing":"0001553350-25-000148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335025000148/ownership.xml","form_type":"4"}},{"id":990203,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":24608,"kind":"person","name":"McGeorge Anne","position":1,"cik":"0001779934","reported_name":"McGeorge Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-24T22:26:26.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":67901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in full on Issuer's 2026 annual stockholder meeting date, subject to continued service with the Issuer through such vesting date."}],"balance_after":251247,"source":{"system":"sec-edgar","filing":"0001553350-25-000148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335025000148/ownership.xml","form_type":"4"}},{"id":990200,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28032,"kind":"person","name":"Kaushal Mohit","position":1,"cik":"0001683021","reported_name":"Kaushal Mohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-24T22:25:08.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":40123,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units that were fully vested upon grant."}],"balance_after":268302,"source":{"system":"sec-edgar","filing":"0001553350-25-000147","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335025000147/ownership.xml","form_type":"4"}},{"id":990199,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28032,"kind":"person","name":"Kaushal Mohit","position":1,"cik":"0001683021","reported_name":"Kaushal Mohit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-24T22:25:08.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":50926,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in full on Issuer's 2026 annual stockholder meeting date, subject to continued service with the Issuer through such vesting date."}],"balance_after":228179,"source":{"system":"sec-edgar","filing":"0001553350-25-000147","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335025000147/ownership.xml","form_type":"4"}},{"id":990202,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28028,"kind":"person","name":"Johnson Karen Marie","position":1,"cik":"0001892819","reported_name":"Johnson Karen Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-24T22:21:35.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":37037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units that were fully vested upon grant."}],"balance_after":288286,"source":{"system":"sec-edgar","filing":"0001553350-25-000145","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335025000145/ownership.xml","form_type":"4"}},{"id":990201,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28028,"kind":"person","name":"Johnson Karen Marie","position":1,"cik":"0001892819","reported_name":"Johnson Karen Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-24T22:21:35.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":47840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in full on Issuer's 2026 annual stockholder meeting date, subject to continued service with the Issuer through such vesting date."}],"balance_after":251249,"source":{"system":"sec-edgar","filing":"0001553350-25-000145","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335025000145/ownership.xml","form_type":"4"}},{"id":990198,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28031,"kind":"person","name":"Pacala Mark L","position":1,"cik":"0001321250","reported_name":"Pacala Mark L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-24T22:21:04.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":35494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units that were fully vested upon grant."}],"balance_after":256761,"source":{"system":"sec-edgar","filing":"0001553350-25-000144","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335025000144/ownership.xml","form_type":"4"}},{"id":990197,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28031,"kind":"person","name":"Pacala Mark L","position":1,"cik":"0001321250","reported_name":"Pacala Mark L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-24T22:21:04.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":46296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in full on Issuer's 2026 annual stockholder meeting date, subject to continued service with the Issuer through such vesting date."}],"balance_after":221267,"source":{"system":"sec-edgar","filing":"0001553350-25-000144","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335025000144/ownership.xml","form_type":"4"}},{"id":990196,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":20372,"kind":"person","name":"Hively Brad","position":1,"cik":"0001891124","reported_name":"Hively Brad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-24T22:20:23.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":32407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units that were fully vested upon grant."}],"balance_after":697054,"source":{"system":"sec-edgar","filing":"0001553350-25-000143","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335025000143/ownership.xml","form_type":"4"}},{"id":990195,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":20372,"kind":"person","name":"Hively Brad","position":1,"cik":"0001891124","reported_name":"Hively Brad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-24T22:20:23.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":41667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in full on Issuer's 2026 annual stockholder meeting date, subject to continued service with the Issuer through such vesting date."}],"balance_after":664647,"source":{"system":"sec-edgar","filing":"0001553350-25-000143","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335025000143/ownership.xml","form_type":"4"}},{"id":990330,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":72423,"kind":"person","name":"Ling Gabriel","position":1,"cik":"0001945281","reported_name":"Ling Gabriel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-24T17:23:29.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":37037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":". Represents restricted stock units that were fully vested upon grant."}],"balance_after":333539,"source":{"system":"sec-edgar","filing":"0001553350-25-000146","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1945281/000155335025000146/ownership.xml","form_type":"4"}},{"id":990329,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":72423,"kind":"person","name":"Ling Gabriel","position":1,"cik":"0001945281","reported_name":"Ling Gabriel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-24T17:23:29.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":46296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in full on Issuer's 2026 annual stockholder meeting date, subject to continued service with the Issuer through such vesting date."}],"balance_after":296502,"source":{"system":"sec-edgar","filing":"0001553350-25-000146","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945281/000155335025000146/ownership.xml","form_type":"4"}},{"id":992572,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28031,"kind":"person","name":"Pacala Mark L","position":1,"cik":"0001321250","reported_name":"Pacala Mark L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-20T21:55:03.000Z","date":"2025-11-18","kind":"sale","planned":false,"acquired":false,"shares":46630,"price":4,"value":186520.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents sale of Common Stock acquired from previously vested RSU awards."}],"balance_after":174971,"source":{"system":"sec-edgar","filing":"0001079973-25-001813","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997325001813/ownership.xml","form_type":"4"}},{"id":992571,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28031,"kind":"person","name":"Pacala Mark L","position":1,"cik":"0001321250","reported_name":"Pacala Mark L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-20T21:55:03.000Z","date":"2025-11-18","kind":"sale","planned":false,"acquired":false,"shares":1210,"price":4,"value":4840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents sale of Common Stock acquired from previously vested RSU awards."}],"balance_after":221601,"source":{"system":"sec-edgar","filing":"0001079973-25-001813","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997325001813/ownership.xml","form_type":"4"}},{"id":992570,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28031,"kind":"person","name":"Pacala Mark L","position":1,"cik":"0001321250","reported_name":"Pacala Mark L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-20T21:55:03.000Z","date":"2025-11-18","kind":"sale","planned":false,"acquired":false,"shares":2160,"price":4,"value":8640.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents sale of Common Stock acquired from previously vested RSU awards."}],"balance_after":222811,"source":{"system":"sec-edgar","filing":"0001079973-25-001813","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997325001813/ownership.xml","form_type":"4"}},{"id":992664,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":72423,"kind":"person","name":"Ling Gabriel","position":1,"cik":"0001945281","reported_name":"Ling Gabriel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-20T16:02:04.000Z","date":"2025-11-18","kind":"other","planned":false,"acquired":true,"shares":141149,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of shares of common stock of the Issuer received by the reporting person through an in-kind distribution by M33 Growth I, L.P. to its limited partners and on a pro rata basis in accordance with their pecuniary interests therein in reliance on Rules 16a-9 and 16a-13 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Consists of shares of common stock of the Issuer received by the reporting person through an in-kind distribution by M33 Growth I, L.P. to its limited partners and on a pro rata basis in accordance with their pecuniary interests therein in reliance on Rules 16a-9 and 16a-13 under the Securities Exchange Act of 1934, as amended."}],"balance_after":250206,"source":{"system":"sec-edgar","filing":"0001213900-25-113114","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1945281/000121390025113114/ownership.xml","form_type":"4"}},{"id":992647,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":72827,"kind":"person","name":"M33 Growth I L.P.","position":1,"cik":"0001718621","reported_name":"M33 Growth I L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72828,"kind":"person","name":"M33 Growth I GP LLC","position":2,"cik":"0001894303","reported_name":"M33 Growth I GP LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72829,"kind":"person","name":"TOI M, LLC","position":3,"cik":"0001892968","reported_name":"TOI M, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-20T16:02:03.000Z","date":"2025-11-18","kind":"other","planned":false,"acquired":false,"shares":2500000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 18, 2025, TOI M, LLC made a distribution in-kind of 590,892 shares of the Issuer's common stock to its members, including 11,818 shares distributed to M33 Growth I L.P. (\"M33 LP\"). Also on November 18, 2025, M33 LP made a distribution-in-kind of 2,500,000 shares of the Issuer's common stock to its limited partners."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 18, 2025, TOI M, LLC made a distribution in-kind of 590,892 shares of the Issuer's common stock to its members, including 11,818 shares distributed to M33 Growth I L.P. (\"M33 LP\"). Also on November 18, 2025, M33 LP made a distribution-in-kind of 2,500,000 shares of the Issuer's common stock to its limited partners."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"M33 Growth I GP LLC is the general partner of M33 LP and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein."}],"balance_after":5444207,"source":{"system":"sec-edgar","filing":"0001213900-25-113113","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1894303/000121390025113113/ownership.xml","form_type":"4"}},{"id":992646,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":72827,"kind":"person","name":"M33 Growth I L.P.","position":1,"cik":"0001718621","reported_name":"M33 Growth I L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72828,"kind":"person","name":"M33 Growth I GP LLC","position":2,"cik":"0001894303","reported_name":"M33 Growth I GP LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72829,"kind":"person","name":"TOI M, LLC","position":3,"cik":"0001892968","reported_name":"TOI M, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-20T16:02:03.000Z","date":"2025-11-18","kind":"other","planned":false,"acquired":true,"shares":11818,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 18, 2025, TOI M, LLC made a distribution in-kind of 590,892 shares of the Issuer's common stock to its members, including 11,818 shares distributed to M33 Growth I L.P. (\"M33 LP\"). Also on November 18, 2025, M33 LP made a distribution-in-kind of 2,500,000 shares of the Issuer's common stock to its limited partners."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 18, 2025, TOI M, LLC made a distribution in-kind of 590,892 shares of the Issuer's common stock to its members, including 11,818 shares distributed to M33 Growth I L.P. (\"M33 LP\"). Also on November 18, 2025, M33 LP made a distribution-in-kind of 2,500,000 shares of the Issuer's common stock to its limited partners."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"M33 Growth I GP LLC is the general partner of M33 LP and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein."}],"balance_after":7944207,"source":{"system":"sec-edgar","filing":"0001213900-25-113113","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1894303/000121390025113113/ownership.xml","form_type":"4"}},{"id":992645,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":72827,"kind":"person","name":"M33 Growth I L.P.","position":1,"cik":"0001718621","reported_name":"M33 Growth I L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72828,"kind":"person","name":"M33 Growth I GP LLC","position":2,"cik":"0001894303","reported_name":"M33 Growth I GP LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":72829,"kind":"person","name":"TOI M, LLC","position":3,"cik":"0001892968","reported_name":"TOI M, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-20T16:02:03.000Z","date":"2025-11-18","kind":"other","planned":false,"acquired":false,"shares":590892,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 18, 2025, TOI M, LLC made a distribution in-kind of 590,892 shares of the Issuer's common stock to its members, including 11,818 shares distributed to M33 Growth I L.P. (\"M33 LP\"). Also on November 18, 2025, M33 LP made a distribution-in-kind of 2,500,000 shares of the Issuer's common stock to its limited partners."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 18, 2025, TOI M, LLC made a distribution in-kind of 590,892 shares of the Issuer's common stock to its members, including 11,818 shares distributed to M33 Growth I L.P. (\"M33 LP\"). Also on November 18, 2025, M33 LP made a distribution-in-kind of 2,500,000 shares of the Issuer's common stock to its limited partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities were held by TOI M, LLC."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-25-113113","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894303/000121390025113113/ownership.xml","form_type":"4"}},{"id":993907,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44753,"kind":"person","name":"Virnich Daniel","position":1,"cik":"0001891107","reported_name":"Virnich Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-19T23:03:11.000Z","date":"2025-11-17","kind":"grant","planned":false,"acquired":true,"shares":6464,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSU awards that were fully vested upon grant, net of withholding tax obligations."}],"balance_after":1799984,"source":{"system":"sec-edgar","filing":"0001079973-25-001809","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997325001809/ownership.xml","form_type":"4"}},{"id":993906,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":30089,"kind":"person","name":"Podnos Yale","position":1,"cik":"0001891104","reported_name":"Podnos Yale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-19T23:01:50.000Z","date":"2025-11-17","kind":"grant","planned":false,"acquired":true,"shares":2086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSU awards that were fully vested upon grant, net of withholding tax obligations."}],"balance_after":237930,"source":{"system":"sec-edgar","filing":"0001079973-25-001807","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997325001807/ownership.xml","form_type":"4"}},{"id":994223,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44812,"kind":"person","name":"Carter Robert Ross","position":1,"cik":"0002039341","reported_name":"Carter Robert Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-19T23:00:18.000Z","date":"2025-11-17","kind":"grant","planned":false,"acquired":true,"shares":195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSU awards that were fully vested upon grant, net of withholding tax obligations."}],"balance_after":235369,"source":{"system":"sec-edgar","filing":"0001079973-25-001805","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039341/000107997325001805/ownership.xml","form_type":"4"}},{"id":998931,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44753,"kind":"person","name":"Virnich Daniel","position":1,"cik":"0001891107","reported_name":"Virnich Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-14T21:30:04.000Z","date":"2025-11-12","kind":"grant","planned":false,"acquired":true,"shares":6211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSU awards that were fully vested upon grant, net of withholding tax obligations."}],"balance_after":1793520,"source":{"system":"sec-edgar","filing":"0001079973-25-001765","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997325001765/ownership.xml","form_type":"4"}},{"id":998939,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":30089,"kind":"person","name":"Podnos Yale","position":1,"cik":"0001891104","reported_name":"Podnos Yale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-14T21:30:02.000Z","date":"2025-11-12","kind":"grant","planned":false,"acquired":true,"shares":1202,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSU awards that were fully vested upon grant, net of withholding tax obligations."}],"balance_after":235844,"source":{"system":"sec-edgar","filing":"0001079973-25-001764","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997325001764/ownership.xml","form_type":"4"}},{"id":998938,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":30089,"kind":"person","name":"Podnos Yale","position":1,"cik":"0001891104","reported_name":"Podnos Yale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-14T21:30:02.000Z","date":"2025-11-12","kind":"grant","planned":false,"acquired":true,"shares":306,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSU awards that were fully vested upon grant, net of withholding tax obligations."}],"balance_after":234642,"source":{"system":"sec-edgar","filing":"0001079973-25-001764","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997325001764/ownership.xml","form_type":"4"}},{"id":1046927,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":72827,"kind":"person","name":"M33 Growth I L.P.","position":1,"cik":"0001718621","reported_name":"M33 Growth I L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72828,"kind":"person","name":"M33 Growth I GP LLC","position":2,"cik":"0001894303","reported_name":"M33 Growth I GP LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72829,"kind":"person","name":"TOI M, LLC","position":3,"cik":"0001892968","reported_name":"TOI M, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-05T06:12:18.000Z","date":"2025-09-04","kind":"sale","planned":false,"acquired":false,"shares":681832,"price":3.09,"value":2106860.88,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held by TOI M, LLC."}],"balance_after":590892,"source":{"system":"sec-edgar","filing":"0001213900-25-084700","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1894303/000121390025084700/ownership.xml","form_type":"4"}},{"id":1046926,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":72827,"kind":"person","name":"M33 Growth I L.P.","position":1,"cik":"0001718621","reported_name":"M33 Growth I L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72828,"kind":"person","name":"M33 Growth I GP LLC","position":2,"cik":"0001894303","reported_name":"M33 Growth I GP LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72829,"kind":"person","name":"TOI M, LLC","position":3,"cik":"0001892968","reported_name":"TOI M, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-05T06:12:18.000Z","date":"2025-09-04","kind":"sale","planned":false,"acquired":false,"shares":6018168,"price":3.09,"value":18596139.12,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"M33 Growth I GP LLC (\"M33 LLC\") is the general partner of M33 Growth I L.P. (\"M33 LP\") and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein."}],"balance_after":7932389,"source":{"system":"sec-edgar","filing":"0001213900-25-084700","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894303/000121390025084700/ownership.xml","form_type":"4"}},{"id":1059309,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":20372,"kind":"person","name":"Hively Brad","position":1,"cik":"0001891124","reported_name":"Hively Brad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2025-08-21T19:13:31.000Z","date":"2025-08-19","kind":"sale","planned":false,"acquired":false,"shares":20221,"price":4.06,"value":82097.26,"ownership":{"direct":true},"balance_after":622980,"source":{"system":"sec-edgar","filing":"0000935836-25-000552","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000093583625000552/ownership.xml","form_type":"4"}},{"id":1080836,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-28T21:08:48.000Z","date":"2025-07-24","kind":"other","planned":false,"acquired":false,"shares":287756,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"RAB Ventures (DFP) LLC (\"RAB Ventures\") distributed 287,756 shares to one of its members, Boro Partners Fund 1 (\"Boro\") in accordance with Boro's beneficial interest in RAB Ventures. The reporting person is a 10% beneficial owner of Boro, but disclaims investment control over Boro. The reporting person disclaims beneficial ownership of these securities except to the extent of the reporting person's pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The distributed shares were owned by RAB Ventures, an entity controlled by the reporting person."}],"balance_after":2635881,"source":{"system":"sec-edgar","filing":"0000935836-25-000475","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000093583625000475/ownership.xml","form_type":"4"}},{"id":1082215,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":51489,"kind":"person","name":"England Kristin","position":1,"cik":"0002078090","reported_name":"England Kristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Administrative Officer"}}],"security":"Common Stock","published_at":"2025-07-24T23:51:20.000Z","date":"2025-07-22","kind":"grant","planned":false,"acquired":true,"shares":98037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSU awards that were fully vested upon grant, net of withholding tax obligations"}],"balance_after":98037,"source":{"system":"sec-edgar","filing":"0000935836-25-000470","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000093583625000470/ownership.xml","form_type":"4"}},{"id":1103096,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Warrant","published_at":"2025-06-24T19:17:42.000Z","date":"2025-06-17","kind":"other","planned":false,"acquired":false,"shares":679224,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The exercise of the Common Warrant by RAB Ventures (DFP) LLC is exempt pursuant to Rule 16b-6."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Securities are owned by RAB Ventures (DFP) LLC, an entity controlled by the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of the reporting person's pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":1.198,"exercise_date":"2025-03-26","expiration_date":"2030-03-26","underlying":"Common Stock","underlying_shares":679224},"source":{"system":"sec-edgar","filing":"0000935836-25-000435","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000093583625000435/ownership.xml","form_type":"4"}},{"id":1103095,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T19:17:42.000Z","date":"2025-06-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":311128,"price":2.6154,"value":813724.1712,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the net exercise of a Common Stock Purchase Warrant (\"Common Warrant\") to purchase shares of common stock. The Common Warrant refers to such net exercise transaction as a \"Cashless Exercise.\" In connection with the Cashless Exercise, the Issuer and RAB Ventures (DFP) LLC entered into a Waiver Agreement, pursuant to which the Issuer agreed to waive the Common Warrant provision restricting Cashless Exercises to circumstances where the resale of the underlying shares of common stock is not covered by an effective registration statement under the Securities Act of 1933, as amended."},{"field":"shares","element":"transactionShares","label":"F3","text":"RAB Ventures (DFP) LLC received 368,096 shares of common stock on a net exercise of the Common Warrant to purchase 679,224 shares of common stock. The Issuer withheld 311,128 shares of common stock underlying the Common Warrant for payment of the exercise price, using the fair market value of the common stock on the date of exercise, June 17, 2025, of $2.6154. The fair market value of the common stock was determined based on the average of the volume weighted average price on each of the five (5) consecutive trading days ending immediately prior to the date of exercise, pursuant to the terms of the Common Warrant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Securities are owned by RAB Ventures (DFP) LLC, an entity controlled by the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of the reporting person's pecuniary interest therein."}],"balance_after":2923637,"source":{"system":"sec-edgar","filing":"0000935836-25-000435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000093583625000435/ownership.xml","form_type":"4"}},{"id":1103094,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T19:17:42.000Z","date":"2025-06-17","kind":"other","planned":false,"acquired":true,"shares":679224,"price":1.198,"value":813710.352,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The exercise of the Common Warrant by RAB Ventures (DFP) LLC is exempt pursuant to Rule 16b-6."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Securities are owned by RAB Ventures (DFP) LLC, an entity controlled by the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of the reporting person's pecuniary interest therein."}],"balance_after":3234765,"source":{"system":"sec-edgar","filing":"0000935836-25-000435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000093583625000435/ownership.xml","form_type":"4"}},{"id":1105390,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Equivalent Preferred Stock","published_at":"2025-06-20T20:59:24.000Z","date":"2025-06-18","kind":"exercise","planned":false,"acquired":false,"shares":6204,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Preferred Stock is convertible into 100 shares of Common Stock. No consideration was paid in connection with the conversion."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion of shares of Class A Common Equivalent Preferred Stock, par value $0.0001 (the \"Preferred Stock\") into shares of the Issuer's common stock, par value $0.0001 (the \"Common Stock\") in accordance with and pursuant to the Certificate of Designation of Preferences, Rights and Limitations of Series A Common Stock Equivalent Convertible Preferred Stock (the \"Certificate of Designation\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Preferred Stock is convertible at any time at the option of the reporting person pursuant to the Certificate of Designation and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Preferred Stock is convertible at any time at the option of the reporting person pursuant to the Certificate of Designation and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities are owned by Helen Barasch Family Trust #1, an affiliate of the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of the reporting person's pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":620400},"source":{"system":"sec-edgar","filing":"0001079973-25-001047","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000107997325001047/ownership.xml","form_type":"4"}},{"id":1105389,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Equivalent Preferred Stock","published_at":"2025-06-20T20:59:24.000Z","date":"2025-06-17","kind":"exercise","planned":false,"acquired":false,"shares":1595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Preferred Stock is convertible into 100 shares of Common Stock. No consideration was paid in connection with the conversion."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion of shares of Class A Common Equivalent Preferred Stock, par value $0.0001 (the \"Preferred Stock\") into shares of the Issuer's common stock, par value $0.0001 (the \"Common Stock\") in accordance with and pursuant to the Certificate of Designation of Preferences, Rights and Limitations of Series A Common Stock Equivalent Convertible Preferred Stock (the \"Certificate of Designation\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Preferred Stock is convertible at any time at the option of the reporting person pursuant to the Certificate of Designation and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Preferred Stock is convertible at any time at the option of the reporting person pursuant to the Certificate of Designation and has no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":159500},"source":{"system":"sec-edgar","filing":"0001079973-25-001047","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000107997325001047/ownership.xml","form_type":"4"}},{"id":1105388,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-20T20:59:24.000Z","date":"2025-06-18","kind":"exercise","planned":false,"acquired":true,"shares":620400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion of shares of Class A Common Equivalent Preferred Stock, par value $0.0001 (the \"Preferred Stock\") into shares of the Issuer's common stock, par value $0.0001 (the \"Common Stock\") in accordance with and pursuant to the Certificate of Designation of Preferences, Rights and Limitations of Series A Common Stock Equivalent Convertible Preferred Stock (the \"Certificate of Designation\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Preferred Stock is convertible into 100 shares of Common Stock. No consideration was paid in connection with the conversion."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Securities are owned by Helen Barasch Family Trust #1, an affiliate of the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of the reporting person's pecuniary interest therein."}],"balance_after":2555541,"source":{"system":"sec-edgar","filing":"0001079973-25-001047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000107997325001047/ownership.xml","form_type":"4"}},{"id":1105387,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":76540,"kind":"person","name":"BARASCH RICHARD A","position":1,"cik":"0001076341","reported_name":"BARASCH RICHARD A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-20T20:59:24.000Z","date":"2025-06-17","kind":"exercise","planned":false,"acquired":true,"shares":159500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion of shares of Class A Common Equivalent Preferred Stock, par value $0.0001 (the \"Preferred Stock\") into shares of the Issuer's common stock, par value $0.0001 (the \"Common Stock\") in accordance with and pursuant to the Certificate of Designation of Preferences, Rights and Limitations of Series A Common Stock Equivalent Convertible Preferred Stock (the \"Certificate of Designation\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Preferred Stock is convertible into 100 shares of Common Stock. No consideration was paid in connection with the conversion."}],"balance_after":1935141,"source":{"system":"sec-edgar","filing":"0001079973-25-001047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1076341/000107997325001047/ownership.xml","form_type":"4"}},{"id":1118224,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":72827,"kind":"person","name":"M33 Growth I L.P.","position":1,"cik":"0001718621","reported_name":"M33 Growth I L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72828,"kind":"person","name":"M33 Growth I GP LLC","position":2,"cik":"0001894303","reported_name":"M33 Growth I GP LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72829,"kind":"person","name":"TOI M, LLC","position":3,"cik":"0001892968","reported_name":"TOI M, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-09T16:15:23.000Z","date":"2025-06-05","kind":"sale","planned":false,"acquired":false,"shares":76324,"price":3.05,"value":232788.2,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held by TOI M, LLC."}],"balance_after":1272724,"source":{"system":"sec-edgar","filing":"0001213900-25-052626","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1894303/000121390025052626/ownership.xml","form_type":"4"}},{"id":1118223,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":72827,"kind":"person","name":"M33 Growth I L.P.","position":1,"cik":"0001718621","reported_name":"M33 Growth I L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72828,"kind":"person","name":"M33 Growth I GP LLC","position":2,"cik":"0001894303","reported_name":"M33 Growth I GP LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72829,"kind":"person","name":"TOI M, LLC","position":3,"cik":"0001892968","reported_name":"TOI M, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-06-09T16:15:23.000Z","date":"2025-06-05","kind":"sale","planned":false,"acquired":false,"shares":673676,"price":3.05,"value":2054711.8,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"M33 Growth I GP LLC (\"M33 LLC\") is the general partner of M33 Growth I L.P. (\"M33 LP\") and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein."}],"balance_after":13950557,"source":{"system":"sec-edgar","filing":"0001213900-25-052626","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894303/000121390025052626/ownership.xml","form_type":"4"}},{"id":1121459,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":20372,"kind":"person","name":"Hively Brad","position":1,"cik":"0001891124","reported_name":"Hively Brad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-05T22:51:15.000Z","date":"2025-06-03","kind":"exercise","planned":false,"acquired":true,"shares":946460,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options vested monthly for 48 months following December 2, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Pursuant to a Transition Agreement with the Reporting Person, all unvested options were cancelled after June 30, 2024."}],"balance_after":0,"derivative":{"exercise_price":0.85,"expiration_date":"2029-12-02","underlying":"Common Stock","underlying_shares":946460},"source":{"system":"sec-edgar","filing":"0000935836-25-000416","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000093583625000416/ownership.xml","form_type":"4"}},{"id":1121458,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":20372,"kind":"person","name":"Hively Brad","position":1,"cik":"0001891124","reported_name":"Hively Brad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-05T22:51:15.000Z","date":"2025-06-03","kind":"exercise","planned":false,"acquired":true,"shares":131297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options vested monthly starting November 17, 2022, with cancellation of remaining options pursuant to Note 6 below."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Pursuant to a Transition Agreement with the Reporting Person, all unvested options were cancelled after June 30, 2024."}],"balance_after":0,"derivative":{"exercise_price":1.87,"expiration_date":"2032-11-17","underlying":"Common Stock","underlying_shares":131297},"source":{"system":"sec-edgar","filing":"0000935836-25-000416","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000093583625000416/ownership.xml","form_type":"4"}},{"id":1121457,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":20372,"kind":"person","name":"Hively Brad","position":1,"cik":"0001891124","reported_name":"Hively Brad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-05T22:51:15.000Z","date":"2025-06-03","kind":"exercise","planned":false,"acquired":true,"shares":105320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options vested monthly starting March 17, 2023, with cancellation of remaining options pursuant to Note 6 below."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Pursuant to a Transition Agreement with the Reporting Person, all unvested options were cancelled after June 30, 2024."}],"balance_after":0,"derivative":{"exercise_price":0.481,"expiration_date":"2033-03-17","underlying":"Common Stock","underlying_shares":105320},"source":{"system":"sec-edgar","filing":"0000935836-25-000416","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000093583625000416/ownership.xml","form_type":"4"}},{"id":1121456,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":20372,"kind":"person","name":"Hively Brad","position":1,"cik":"0001891124","reported_name":"Hively Brad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-05T22:51:15.000Z","date":"2025-06-03","kind":"exercise","planned":false,"acquired":true,"shares":684528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vested monthly for 36 months following November 12, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Pursuant to a Transition Agreement with the Reporting Person, all unvested options were cancelled after June 30, 2024."}],"balance_after":0,"derivative":{"exercise_price":0.85,"expiration_date":"2029-12-02","underlying":"Common Stock","underlying_shares":684528},"source":{"system":"sec-edgar","filing":"0000935836-25-000416","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000093583625000416/ownership.xml","form_type":"4"}},{"id":1121455,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":20372,"kind":"person","name":"Hively Brad","position":1,"cik":"0001891124","reported_name":"Hively Brad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T22:51:15.000Z","date":"2025-06-03","kind":"sale","planned":false,"acquired":false,"shares":108532,"price":2.8703,"value":311519.3996,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents sale of Common Stock acquired from previously vested RSU awards."}],"balance_after":603501,"source":{"system":"sec-edgar","filing":"0000935836-25-000416","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000093583625000416/ownership.xml","form_type":"4"}},{"id":1121454,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":20372,"kind":"person","name":"Hively Brad","position":1,"cik":"0001891124","reported_name":"Hively Brad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T22:51:15.000Z","date":"2025-06-03","kind":"sale","planned":false,"acquired":false,"shares":1867605,"price":2.8703,"value":5360586.6315,"ownership":{"direct":true},"balance_after":712033,"source":{"system":"sec-edgar","filing":"0000935836-25-000416","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000093583625000416/ownership.xml","form_type":"4"}},{"id":1121453,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":20372,"kind":"person","name":"Hively Brad","position":1,"cik":"0001891124","reported_name":"Hively Brad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T22:51:15.000Z","date":"2025-06-03","kind":"exercise","planned":false,"acquired":true,"shares":946460,"price":0.85,"value":804491.0,"ownership":{"direct":true},"balance_after":2579638,"source":{"system":"sec-edgar","filing":"0000935836-25-000416","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000093583625000416/ownership.xml","form_type":"4"}},{"id":1121452,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":20372,"kind":"person","name":"Hively Brad","position":1,"cik":"0001891124","reported_name":"Hively Brad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T22:51:15.000Z","date":"2025-06-03","kind":"exercise","planned":false,"acquired":true,"shares":131297,"price":1.87,"value":245525.39,"ownership":{"direct":true},"balance_after":1633178,"source":{"system":"sec-edgar","filing":"0000935836-25-000416","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000093583625000416/ownership.xml","form_type":"4"}}],"next_cursor":"2025-06-05T22:51:15.000000Z,1121452"}